ArticleAntimicrobial resistance and infection control2025
Adherence to national recommendations for the control of multidrug-resistant microorganisms in Swiss acute care hospitals - an updated national survey.
Article in Antimicrobial resistance and infection control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundScreening patients at risk of multidrug-resistant organism (MDRO) carriage is a cornerstone of infection prevention and control to identify carriers and prevent transmission. In 2021, the Swiss Centre for Infection Prevention Swissnoso published the first national recommendations for the prevention and control of MDROs, including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales, carbapenemase-producing Enterobacterales (CPE), and Candida auris. This study evaluated the adherence of institutional guidelines to these recommendations across Swiss acute care hospitals and identified barriers to their implementation.
methodsA 28-item online survey was conducted in spring 2023 among Swiss acute care hospitals. The primary outcome was the adherence of institutional guidelines to national recommendations, assessed using a weighted score that accounted for different grades of recommendation for on-admission screening. Secondary outcomes included adherence to recommended body sites for screening, the implementation of universal screening during hospitalization, and perceived barriers to implementation.
resultsA total of 68 of 142 invited hospitals (47%) responded. Overall adherence with national recommendations for on-admission screening across the five MDRO targets was 69% (weighted score; interquartile range [IQR], 55–86%). Screening adherence was higher for patients exposed to foreign healthcare systems compared to those exposed to Swiss healthcare institutions. Recommendations concerning screening of specific body sites were less frequently followed when they were only conditionally recommended. Only 12 institutions (20%) reported conducting universal cross-sectional screening during hospitalisation in designated high-risk wards. Non-adherence of healthcare personnel was perceived as the most significant barrier to guideline implementation.
conclusionsSwiss acute care hospitals showed moderate overall adherence to national MDRO prevention and control recommendations in non-outbreak settings. Adherence was particularly low for on-admission screening of patients transferred from Swiss healthcare institutions experiencing ongoing outbreaks and for active surveillance cultures during hospitalization in high-risk units. While the publication of national guidelines was an important step toward MDRO transmission prevention, ensuring consistent implementation remains a significant challenge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.